Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secutrelvir in Participants With COVID-19
NCT07746544Phase 3Recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Aug 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 3 trial of secutrelvir in coronavirus disease 2019 (COVID-19), sponsored by Shionogi & Co., Ltd.. Started Aug 2026; status: recruiting.
02
Drugs
secutrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07746544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746544.